FIGURE

Fig. 5.

ID
ZDB-FIG-240311-23
Publication
Del Rosario Hernández et al., 2024 - Drug repurposing for neurodegenerative diseases using Zebrafish behavioral profiles
Other Figures
All Figure Page
Back to All Figure Page
Fig. 5.

Predominant targets and pathways perturbed by CsA-like compounds.

(A) Top 10 targets affected by the 876 compounds in the Cayman Chemical FDA-approved Drug Library. (B) Top 10 targets affected by CsA and the 64 CsA-like compounds found in our clustering analyses. (C) Top 25 Wikipathways, Reactome, KEGG, and PANTHER pathways containing targets affected by CsA-like compounds.

Expression Data

Expression Detail
Antibody Labeling
Phenotype Data

Phenotype Detail
Acknowledgments
This image is the copyrighted work of the attributed author or publisher, and ZFIN has permission only to display this image to its users. Additional permissions should be obtained from the applicable author or publisher of the image. Full text @ Biomed. Pharmacother.